NEO: BRIEF-Neogenomics says received notice from affiliated oncology practices of termination of commercial deal, effective May 14 - filing
(Other side of the coin on NEO's business development. Mgmt had reported a trend in pathology labs terminating outsourcing contracts because of the TC grandfather sunset. This one appears to be a big termination, although the end of the contract is next May, with plenty of time to replace the business lost.)
Nov 18 (Reuters) - Neogenomics Inc : * On November 14th,co received notice from affiliated oncology practices of
termination of commercial deal between parties effective may 14, 2014 * Group comprised 15.8% of the company's revenue for the nine months ended
September 30, 2013 - SEC filing * Co understands that client intends to internalize many of tests that co has
been performing on client's behalf * Says is in ongoing discussions with this client to determine if a new
agreement can be reached on mutually acceptable terms * Source text for Eikon * Further company coverage
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.